£ 10 million India-UK collaboration to beat Cancer


Cancer Research UK is partnering with the Department of Biotechnology of India for a 10 million pound research 5- year initiative focussed on finding affordable approaches to cancer. India has been a pioneer in finding low cost medicines facilitating access to medicines which were earlier critical but beyond the reach of the common man. This innovative initiative is believed to build on the scientific strengths of India and the UK, according to the Cancer Research UK website: https://affordable-approaches-to-cancer.indiaalliance.org/
The bilateral Advisory Panel has set seven research challenges under the theme of affordable approaches to cancer. These include identifying and quantifying cancer risk factors to better understand regional variations in incidence, enabling new approaches to cancer prevention, devising affordable screening tools to improve early detection of cancer, identifying affordable approaches to improve early diagnosis of symptomatic cancers, developing computational approaches that can reduce the cost of cancer care delivery, identifying novel, affordable treatment approaches for hard to treat cancers using small molecules, improving the affordability of effective cancer treatments and developing approaches to improve long-term quality of life in children and young people with cancer.


The bilateral Advisory Panel has set seven research challenges under the theme of affordable approaches to cancer. These include identifying and quantifying cancer risk factors to better understand regional variations in incidence, enabling new approaches to cancer prevention, devising affordable screening tools to improve early detection of cancer, identifying affordable approaches to improve early diagnosis of symptomatic cancers, developing computational approaches that can reduce the cost of cancer care delivery, identifying novel, affordable treatment approaches for hard to treat cancers using small molecules, improving the affordability of effective cancer treatments and developing approaches to improve long-term quality of life in children and young people with cancer.

Indians involved in the research include Professor CS Pramesh, Director of Tata Memorial Hospital, Professor Raj Chopra, Head of division of Cancer therapeutics and director Cancer Research UK Therapeutics Unit, Dr Geetha Manjunath CEO of Non-invasive Risk Assessment and Machine Intelligence, Prof Partha Majumdar, Director of TCJ-ISI Center for Population Genomics, Professor Arnie Purushotam, Director of King’s Health Partners Cancer Centre, Chair of Breast Cancer at King’s College London and Consultant Surgeon at Guy’s and St Thomas NHS Foundation Trust, Professor G K Rath, Head of National Cancer Institute and Chief and Professor of Radiation Oncology, All India Institute of Medical Sciences, Dr Rengaswamy Sankarnarayanan, Senior Visiting Scientist WHO-IARC, Sunil Shah, Founder of 02H Ventures, Dr Anjali Shiras, Scientific Officer, National Center for Cell Science and Vivek Tomar, advocate for Lung Cancer, Clinical Research and timely access to Latest Treatment.

Dr Renu Swarup, Secretary of DBT, speaking about the collaboration has said, “Cancer is a global epidemic that requires radical new approaches through inter-disciplinary and multi-national efforts. The Affordable Approaches to Cancer initiative will provide a catalysing platform for scientists and researchers in the UK and India to co-create solutions for affordable cancer care that improve cancer outcomes around the globe. At DBT our priority is to apply science to solving complex challenges that benefit all humanity and we are glad to be partnering with CRUK to support research across all stages of cancer from prevention to cure to address the formidable challenge of cancer.”

For more information please visit: https://affordable-approaches-to-cancer.indiaalliance.org/

Leave a Reply

Your email address will not be published. Required fields are marked *

five + one =